International Pandemic Response Project

About Aptamerlab

Aptamerlab is a private, service-oriented biotech firm providing end-to-end aptamer discovery and development solutions for clients in diagnostics and therapeutics. Its core technology involves in vitro and in vivo selection of aptamers against complex targets like whole cells and tissues, followed by rigorous characterization and structural analysis. The company has gained recognition through awards like the R-Pharm and Skolkovo startup competition and participates in international collaborative projects. Operating as a specialized CRO, its business model is likely in the early revenue stage, serving academic, pharmaceutical, and diagnostic partners.

Other COVID-19 / Viral Infections Drugs